Sprache: Englisch
Verlag: Cham, Springer International Publishing., 2015
ISBN 10: 3319178067 ISBN 13: 9783319178066
Anbieter: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Deutschland
2015. 235 mm x 155 mm. xiv, 353 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Stamped. Resistance to Targeted Anti-Cancer Therapeutics ; 7. Sprache: Englisch.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 115,23
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 368 | Sprache: Englisch | Produktart: Bücher | This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.
Zustand: Neuf.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 158,26
Anzahl: 3 verfügbar
In den WarenkorbZustand: New.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 154,70
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 2015 edition. 368 pages. 9.25x6.10x1.10 inches. In Stock.
Sprache: Englisch
Verlag: Springer International Publishing, Springer Nature Switzerland, 2015
ISBN 10: 3319178067 ISBN 13: 9783319178066
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 193,34
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: moluna, Greven, Deutschland
EUR 197,89
Anzahl: Mehr als 20 verfügbar
In den WarenkorbGebunden. Zustand: New. Presents updated knowledge on autophagy at the basic level and its potential use in cancer treatment Offers the first book to cover autophagy at the interface of cell biology, immunology and tumor biology Provides a wealth of info.
Sprache: Französisch
Verlag: Médecine Science Publications (4/2003), 2003
ISBN 10: 2257114612 ISBN 13: 9782257114617
Anbieter: BOOKIT!, Genève, Schweiz
Zustand: Used: Like New. LIVRE A L?ETAT DE NEUF. EXPEDIE SOUS 3 JOURS OUVRES. NUMERO DE SUIVI COMMUNIQUE AVANT ENVOI, EMBALLAGE RENFORCE. EAN:9782257114617.